Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C (HCV)”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT02640157
What this trial is testing

A Study Comparing Efficacy and Safety of ABT-493/ABT-530 to Sofosbuvir Dosed With Daclatasvir in Adults With HCV Genotype 3 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusGenotype 3 Hepatitis C Virus
AbbVie 506
Large-scale testing (Phase 3)Study completedNCT02319031
What this trial is testing

Safety and Efficacy Study of the Combination Daclatasvir (60 mg), Sofosbuvir (400 mg) and Ribavirin (Weight-based Dosing) for 12 or 16 Weeks in Subjects With Genotype 3 Chronic HCV Infection With or Without Prior Treatment Experience and Advanced Fibrosis or Compensated Cirrhosis

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 53
Large-scale testing (Phase 3)Study completedNCT02201953
What this trial is testing

Comparison of Sofosbuvir/Velpatasvir Fixed Dose Combination for 12 Weeks With Sofosbuvir and Ribavirin for 24 Weeks in Adults With Chronic Genotype 3 HCV Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 558
Large-scale testing (Phase 3)Study completedNCT01197157
What this trial is testing

Study of the Impact of Nitazoxanide on Chronic Hepatitis Patients

Who this might be right for
Hepatitis C
National Liver Institute, Egypt 200
Testing effectiveness (Phase 2)Study completedNCT00807001
What this trial is testing

Double-Blind, Dose-Escalation Study of IDX184 in Chronic Hepatitis C Treatment-Naïve Subjects

Who this might be right for
Chronic Hepatitis C (HCV)
Merck Sharp & Dohme LLC 41
Not applicableStudy completedNCT01437969
What this trial is testing

Pharmacogenomics Study on IL28B Genetic Variants in Italian Patients With HCV Infection naïve to Treatment.

Who this might be right for
Liver Disease
Casa Sollievo della Sofferenza IRCCS 500
Post-approval studies (Phase 4)Study completedNCT03050905
What this trial is testing

Proof of Concept Study To Evaluate the Efficacy and Justification Of OBV/PTV/r and DSV In Adults With Chronic Hepatitis C Virus Genotype 2K/1B

Who this might be right for
HCV Coinfection
HaEmek Medical Center, Israel 7
Not applicableUnknownNCT03887637
What this trial is testing

Real-world Effectiveness and Safety of Treatment With DAAs in Patients With CHC(Chronic Hepatitis C)

Who this might be right for
Chronic Hepatitis C
Third Affiliated Hospital, Sun Yat-Sen University 180
Not applicableStudy completedNCT03413696
What this trial is testing

Effects of Health Literacy and HCV Knowledge on HCV Treatment Willingness in HIV-coinfected Patients

Who this might be right for
Hepatitis CHepatitis C, ChronicHIV/AIDS
University of California, San Diego 150
Testing effectiveness (Phase 2)Study completedNCT01724086
What this trial is testing

Evaluate the Safety, Tolerability, and Effectiveness of a 12-Week Combination Therapy of TMC647055 and TMC435 With and Without GSK23336805 With a Pharmacokinetic Enhancer With and Without Ribavirin in Patients Infected With Chronic Genotype 1 Hepatitis C Virus

Who this might be right for
Chronic Hepatitis C
Janssen R&D Ireland 90
Early research (Phase 1)Study completedNCT00372983
What this trial is testing

Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy

Who this might be right for
Hepatitis C
Cellectar Biosciences, Inc. 30
Not applicableUnknownNCT02687061
What this trial is testing

Chronic Hepatitis B and C Recall Northern Holland

Who this might be right for
Hepatitis BHepatitis C
Stichting MDL Holland-Noord 300
Not applicableStudy completedNCT02006823
What this trial is testing

Patient Self-management and Gene Guided Therapy for Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Duke University 20
Not applicableStudy completedNCT01577069
What this trial is testing

Predictive Factors of the Treatment Failure in Hepatitis C Virus (HCV) Infected Patients Treated With Telaprevir

Who this might be right for
Chronic Hepatitis C
Association HGE CHU Bordeaux Sud 73
Not applicableStudy completedNCT03303599
What this trial is testing

Study of the Effectiveness and Clinical Practice Use of Glecaprevir Plus Pibrentasvir in Patients With Chronic Hepatitis C Genotypes 1 to 6

Who this might be right for
Hepatitis C
AbbVie 2,118
Testing effectiveness (Phase 2)Study completedNCT01581138
What this trial is testing

VX-222 + Telaprevir + Ribavirin for 12 or 16 Weeks in Treatment-Naive Subjects With Genotype 1a Hepatitis C

Who this might be right for
Chronic Hepatitis C Virus
Vertex Pharmaceuticals Incorporated 64
Not applicableStudy completedNCT02969668
What this trial is testing

Interferon-free Antiviral Treatment of Chronic Hepatitis C Virus Infection Among Opioid-substituted Patients

Who this might be right for
Hepatitis C, ChronicOpioid-Related Disorders
Universitätsklinikum Hamburg-Eppendorf 326
Not applicableUnknownNCT03461250
What this trial is testing

Chronic Hepatitis C in Chronic Hemodialysis Recipients - An Observational Study

Who this might be right for
HCV Infection
Asociacion para el Estudio del Higado 293
Large-scale testing (Phase 3)UnknownNCT03163849
What this trial is testing

Assessment Effects After Direct Acting Antiviral in Chronic Hepatitis c Virus Patients

Who this might be right for
Chronic Hepatitis c
Assiut University 50
Not applicableStudy completedNCT02640547
What this trial is testing

Real World Evidence of the Effectiveness of Paritaprevir/Ritonavir, Ombitasvir, ± Dasabuvir, ± Ribavirin in Patients With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
AbbVie 394
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation